Sanofi partners with leading drugstores for prescription medicine delivery
It is this predicament that Sanofi tries to remedy in their newest collaborations. Dedicated to improving access to healthcare, Sanofi has partnered with Watsons, Southstar Drug, and Rose Pharmacy to offer an easier way for patients to take better care of their health. Patients with diabetes, hypertension, kidney disease, and other lifestyle diseases may now order their prescription medicines either online or via phone, and have them delivered straight to their doors or pick up at their preferred branch sans the waiting. The collaborations started in May 2021, and are continuing to activate even more pharmacies in order to reach more patients. Sanofi’s collaboration with these pharmacies fills the current need and demand for insulin and other medicines that require proper cold chain management. Their respective delivery services ensure that medicines like insulin are properly handled to maintain their efficacy. With just a call or a click, patients and their caregivers can easily order medicines, and are no longer forced to step out of the house and run the risk of exposing themselves to the virus.
Sanofi has provided its expertise on cold chain management and has standardized the handling of these medicines throughout different branches of the pharmacies located strategically in key cities all over the country. Anyone with a valid prescription can avail of the e-pharmacy services especially for prescription medicines. Pharmacies have systems in place on how they will validate the purchase of these products in the e-pharmacy channel as required by law. In a bigger effort to improve healthcare, most critical in these times, these collaborations are not exclusive to Sanofi medicines but include other medicines that need proper cold chain storage handling in order to reach the patients. As a global healthcare leader, this is a bold initiative of Sanofi that patients will be able to obtain insulin in the most convenient way. Sanofi’s newest Second Generation Insulin is also made available through this channel. Compared to the first generation insulin, the newer insulin is recorded to have improved effects on patients’ blood sugar, as well as a lower risk for abnormally low levels of blood sugar. It has also been innovated to have a more gradual drug release and therefore less painful when injected.